Anti-CD19 chimeric antigen receptor T cells (CART-19) for hemotological malignancies therapy.
10.3760/cma.j.issn.0253-2727.2016.02.018
- VernacularTitle:抗CD19嵌合抗原受体修饰的T细胞在血液系统恶性肿瘤中的应用
- Author:
Hejin JIA
;
Weidong HAN
1
Author Information
1. Department of Biological Treatment, The Chinese People's Liberation Army General Hospital, Beijing 100853, China.
- Publication Type:Journal Article
- MeSH:
Hematologic Neoplasms;
therapy;
Humans;
Immunotherapy, Adoptive;
Receptors, Antigen, T-Cell;
Receptors, IgG;
immunology;
T-Lymphocytes
- From:
Chinese Journal of Hematology
2016;37(2):164-168
- CountryChina
- Language:Chinese
